OpenLB
Open Library of Bioscience
Advanced Search
Nature medicine
Nov, 2023;29 (11): 2959.

Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.

Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis K Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Author Information
  1. Jeremy Pettus: Division of Endocrinology, University of California San Diego, La Jolla, CA, USA. jpettus@health.ucsd.edu. ORCID
  2. Schafer C Boeder: Division of Endocrinology, University of California San Diego, La Jolla, CA, USA. ORCID
  3. Mark P Christiansen: Diablo Clinical Research, Walnut Creek, CA, USA.
  4. Douglas S Denham: Clinical Trials of Texas, San Antonio, TX, USA.
  5. Timothy S Bailey: AMCR Institute, Escondido, CA, USA. ORCID
  6. Halis K Akturk: Barbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA. ORCID
  7. Leslie J Klaff: Rainier Clinical Research Center, Renton, WA, USA.
  8. Julio Rosenstock: Dallas Diabetes Research Center, Dallas, TX, USA.
  9. Mickie H M Cheng: Marin Endocrine Care and Research, Greenbrae, CA, USA.
  10. Bruce W Bode: Atlanta Diabetes Associates, Atlanta, GA, USA.
  11. Edgar D Bautista: REMD Biotherapeutics, Camarillo, CA, USA.
  12. Ren Xu: REMD Biotherapeutics, Camarillo, CA, USA.
  13. Hai Yan: REMD Biotherapeutics, Camarillo, CA, USA.
  14. Dung Thai: REMD Biotherapeutics, Camarillo, CA, USA.
  15. Satish K Garg: Barbara Davis Center for Diabetes, University of Colorado Anschutz Campus, Aurora, CO, USA.
  16. Samuel Klein: Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO and Sansum Diabetes Research Institute, Santa Barbara, CA, USA.
PMID: 36932248 DOI: 10.1038/s41591-023-02301-y

Abstract

No abstract text available.

Grants

  1. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  2. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  3. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  4. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  5. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  6. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  7. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  8. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  9. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  10. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  11. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  12. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  13. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  14. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
  15. R44DK108305/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
Published Erratum
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0PublisherCorrection:Glucagonreceptorantagonistvolagidemabtype1diabetes:12-weekrandomizeddouble-blindphase2trial

Similar Articles

Cited By

No available data.